Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cerevel Therapeutics Hldg Inc (CERE)

Cerevel Therapeutics Hldg Inc (CERE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,598,956
  • Shares Outstanding, K 181,576
  • Annual Sales, $ 0 K
  • Annual Income, $ -432,840 K
  • 60-Month Beta 1.48
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 11.31
Trade CERE with:

Options Overview Details

View History
  • Implied Volatility 12.85% ( +1.88%)
  • Historical Volatility 5.35%
  • IV Percentile 8%
  • IV Rank 11.05%
  • IV High 108.75% on 12/06/23
  • IV Low 0.94% on 12/29/23
  • Put/Call Vol Ratio 1.35
  • Today's Volume 399
  • Volume Avg (30-Day) 476
  • Put/Call OI Ratio 0.70
  • Today's Open Interest 45,387
  • Open Int (30-Day) 39,854

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.61
  • Number of Estimates 5
  • High Estimate -0.55
  • Low Estimate -0.70
  • Prior Year -0.67
  • Growth Rate Est. (year over year) +8.96%

Price Performance

See More
Period Period Low Period High Performance
1-Month
41.50 +0.84%
on 04/12/24
42.79 -2.21%
on 03/18/24
-0.03 (-0.07%)
since 03/12/24
3-Month
40.66 +2.93%
on 02/22/24
43.59 -3.99%
on 02/15/24
-0.85 (-1.99%)
since 01/12/24
52-Week
19.59 +113.63%
on 10/04/23
43.59 -3.99%
on 02/15/24
+17.35 (+70.82%)
since 04/12/23

Most Recent Stories

More News
Is AbbVie Stock a Buy Now?

Management pivoting a $300 billion company as quickly as it has is nothing short of remarkable.

ABBV : 162.28 (-2.22%)
CERE : 41.85 (-0.38%)
Is AbbVie Stock a Buy Now?

The company is grappling with losing Humira's patent protection in 2023.

IMGN : 31.23 (unch)
CERE : 41.85 (-0.38%)
ABBV : 162.28 (-2.22%)
4 Top Dividend Stocks Yielding More Than 4% to Buy Hand-Over-Fist This December

These companies offer above-average income streams that should continue rising.

SRC : 42.31 (-1.56%)
CERE : 41.85 (-0.38%)
O : 52.02 (-0.42%)
BEPC : 22.37 (-3.49%)
BEP : 21.04 (-3.31%)
ABBV : 162.28 (-2.22%)
VZ : 39.72 (-1.10%)
AbbVie Just Announced 2 Big Acquisitions: Is This Dividend King a No-Brainer Buy Right Now?

The big drugmaker went on a holiday shopping spree.

AGN.AX : 0.570 (-10.24%)
ABBV : 162.28 (-2.22%)
IMGN : 31.23 (unch)
CERE : 41.85 (-0.38%)
AbbVie's on an Acquisition Binge. Could Your Favorite Biotech Stock Be Next?

Here's what's attracting lucrative buyout offers from big pharmaceutical companies these days.

ABBV : 162.28 (-2.22%)
CERE : 41.85 (-0.38%)
IMGN : 31.23 (unch)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cerevel Therapeutics Holdings, Inc. - CERE

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cerevel Therapeutics Holdings, Inc. ("Cerevel" or the "Company") (NASDAQ: CERE)....

CERE : 41.85 (-0.38%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cerevel Therapeutics Holdings, Inc. - CERE

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cerevel Therapeutics Holdings, Inc. ("Cerevel" or the "Company") (NASDAQ: CERE)....

CERE : 41.85 (-0.38%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cerevel Therapeutics Holdings, Inc. - CERE

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cerevel Therapeutics Holdings, Inc. ("Cerevel" or the "Company") (NASDAQ: CERE)....

CERE : 41.85 (-0.38%)
Why Shares of Cerevel Therapeutics Are Dropping Wednesday

The company reported second-quarter earnings.

CERE : 41.85 (-0.38%)
Quantiphi Collaborates with Cerevel Therapeutics to Harness the Power of Google Cloud's AI in Clinical Workflow Management

/PRNewswire/ -- Quantiphi, an AI-first digital engineering company, today announced that it has entered into a collaboration with Cerevel Therapeutics (Nasdaq:...

CERE : 41.85 (-0.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Cerevel Therapeutics Inc. treats neuroscience diseases. The company's diversified pipeline comprising clinical-stage investigational therapies and several preclinical compounds to treat neuroscience diseases, including schizophrenia, epilepsy, Parkinson's disease and substance use disorder. Cerevel Therapeutics...

See More

Key Turning Points

3rd Resistance Point 42.64
2nd Resistance Point 42.34
1st Resistance Point 42.10
Last Price 41.85
1st Support Level 41.55
2nd Support Level 41.25
3rd Support Level 41.01

See More

52-Week High 43.59
Last Price 41.85
Fibonacci 61.8% 34.42
Fibonacci 50% 31.59
Fibonacci 38.2% 28.76
52-Week Low 19.59

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar